Treatment

We connect RET-positive cancer patients with clinical trials, revealing potential treatment options and helping researchers gather critical information upon which to base their research. We also provide the most up-to-date RET treatment information.

Current RET Treatments

Learn here about the treatment options for patients with RET fusions or other RET alterations, including the RET targeted therapies that work to selectively block the RET molecule.

Learn more

Match to a Clinical Trial

According to the National Institutes of Health, clinical trials are ​​at the heart of all medical advances. Clinical trials help determine whether treatment, prevention and behavior approaches are safe and effective.

Clinical trials offer hope to patients – and critical information to researchers that can lead to improved treatment options.

We provide information about the latest clinical trials for RET-positive patients. Use our tool to match to a trial.

Match to a clinical trial

More About Treatment

LCGS vaccine info for EGFR lung cancer
New Large Study Analyzed Inherited EGFR T790M Mutation and Lung Cancer Risk

New Large Study Analyzed Inherited EGFR T790M Mutation and Lung Cancer Risk

Inherited genetic factors can contribute to EGFR lung cancer risk,…
September 29, 2026 Read More
cancer vaccine success BioNTech
BioNTech BNT116 Cancer Vaccine Shows Promising Early Activity in Resectable NSCLC

BioNTech BNT116 Cancer Vaccine Shows Promising Early Activity in Resectable NSCLC

A new Phase I study, 53% of patients with available…
September 24, 2026 Read More
moderna mrna vaccine for NSCLC
Moderna’s Personalized mRNA Cancer Vaccine Programs in NSCLC

Moderna’s Personalized mRNA Cancer Vaccine Programs in NSCLC

Learn how mRNA cancer vaccines like Moderna's V940 and mRNA-4359…
September 3, 2026 Read More
ctDNA liquid biopsy testing
ctDNA and Liquid Biopsy in RET-Positive Lung Cancer

ctDNA and Liquid Biopsy in RET-Positive Lung Cancer

A simple blood draw can now reveal what's happening inside…
August 12, 2026 Read More
RET inhibitor and chemotherapy treatment for lung cancer
Continuing a RET Inhibitor With Chemotherapy After Progression May Improve Outcomes For RET Lung Cancer Patients

Continuing a RET Inhibitor With Chemotherapy After Progression May Improve Outcomes For RET Lung Cancer Patients

RET Inhibitor with chemotherapy after progression may improve outcomes for…
July 10, 2026 Read More
RET cancer vaccine trial
BioNTech’s BNT116 mRNA cancer vaccine trial currently open at MD Anderson and Johns Hopkins

BioNTech’s BNT116 mRNA cancer vaccine trial currently open at MD Anderson and Johns Hopkins

Exciting news for the RET community! BioNTech’s BNT116 mRNA cancer…
April 27, 2026 Read More
Lilly pharmaceutical clinical trial
Positive Results for Selpercatinib for Early Stage-RET Lung Cancer

Positive Results for Selpercatinib for Early Stage-RET Lung Cancer

Eli Lilly and Company announced positive results from the Phase…
February 17, 2026 Read More
ret lung cancer oncologist newsletter archives
Finding the Right RET Oncologist for Your Cancer Treatment

Finding the Right RET Oncologist for Your Cancer Treatment

Finding the right oncologist and medical care team is one…
February 13, 2026 Read More
2025 IASLC targeted therapies recap
2025 IASLC Targeted Therapies Recap

2025 IASLC Targeted Therapies Recap

#TogetherSeparately: live virtual meetup to summarize data presented in February’s…
March 20, 2025 Read More
View all RET treatment news

More About Treatment

LCGS vaccine info for EGFR lung cancer
New Large Study Analyzed Inherited EGFR T790M Mutation and Lung Cancer Risk

New Large Study Analyzed Inherited EGFR T790M Mutation and Lung Cancer Risk

Inherited genetic factors can contribute to EGFR lung cancer risk,…
September 29, 2026 Read More
cancer vaccine success BioNTech
BioNTech BNT116 Cancer Vaccine Shows Promising Early Activity in Resectable NSCLC

BioNTech BNT116 Cancer Vaccine Shows Promising Early Activity in Resectable NSCLC

A new Phase I study, 53% of patients with available…
September 24, 2026 Read More
moderna mrna vaccine for NSCLC
Moderna’s Personalized mRNA Cancer Vaccine Programs in NSCLC

Moderna’s Personalized mRNA Cancer Vaccine Programs in NSCLC

Learn how mRNA cancer vaccines like Moderna's V940 and mRNA-4359…
September 3, 2026 Read More
ctDNA liquid biopsy testing
ctDNA and Liquid Biopsy in RET-Positive Lung Cancer

ctDNA and Liquid Biopsy in RET-Positive Lung Cancer

A simple blood draw can now reveal what's happening inside…
August 12, 2026 Read More
RET inhibitor and chemotherapy treatment for lung cancer
Continuing a RET Inhibitor With Chemotherapy After Progression May Improve Outcomes For RET Lung Cancer Patients

Continuing a RET Inhibitor With Chemotherapy After Progression May Improve Outcomes For RET Lung Cancer Patients

RET Inhibitor with chemotherapy after progression may improve outcomes for…
July 10, 2026 Read More
RET cancer vaccine trial
BioNTech’s BNT116 mRNA cancer vaccine trial currently open at MD Anderson and Johns Hopkins

BioNTech’s BNT116 mRNA cancer vaccine trial currently open at MD Anderson and Johns Hopkins

Exciting news for the RET community! BioNTech’s BNT116 mRNA cancer…
April 27, 2026 Read More
Lilly pharmaceutical clinical trial
Positive Results for Selpercatinib for Early Stage-RET Lung Cancer

Positive Results for Selpercatinib for Early Stage-RET Lung Cancer

Eli Lilly and Company announced positive results from the Phase…
February 17, 2026 Read More
View all RET treatment news